Riskpilot← Back to searchSign inGet full accessBLIKK ØYEKLINIKK AS
ASActiveOrg 912430278Slemdalsveien 1, 0369 OsloMedical specialists activities · NACE 8622Est. 20135 employeesblikkoyeklinikk.no
Revenue 2024
NOK 5,5M
+14% vs 2023
EBITDA margin
2.9%
-24% vs 2023
Equity ratio
4.4%
Financial strength
Net profit 2024
NOK 0
5 employees
| Revenue | NOK 5,5M | +14% |
| EBITDA | NOK 159K | -24% |
| Net profit | NOK 0 | — |
| Total assets | NOK 916K | -36% |
| Equity | NOK 40K | +0% |
| Employees | 5 | — |
Legal name
BLIKK ØYEKLINIKK AS
Org number
912430278
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
12. september 2013
Share capital
NOK 40 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Drift av øyeklinikk samt deltakelse i annen virksomhet som naturlig kan knyttes til dette.
Address
Slemdalsveien 1, 0369 Oslo
Website
blikkoyeklinikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 035 | 4 833 | 4 889 | 4 842 | 5 521 |
| Staff expenses | −2 188 | −1 994 | −1 955 | −1 940 | −2 278 |
| EBITDA | 481 | 188 | 220 | 209 | 159 |
| Depreciation & amort. | −467 | −398 | −67 | −192 | −161 |
| EBIT | 13 | −210 | 153 | 18 | −1 |
| Net financials | −13 | −16 | −12 | −18 | 1 |
| Profit before tax | −0 | −226 | 141 | 0 | 0 |
| Tax | −0 | −17 | −0 | −0 | −0 |
| Net profit | −0 | −209 | 141 | 0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 733 | 887 | 1 221 | 1 432 | 916 |
| Equity | 108 | −101 | 40 | 40 | 40 |
| Long-term debt | 17 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 607 | 988 | 1 181 | 1 392 | 876 |
| Total debt | 1 625 | 988 | 1 181 | 1 392 | 876 |
EBITDA margin
2.9%
This company
15.8%
Market median
-82% vs market
20202024
Equity ratio
4.4%
This company
38.2%
Market median
-88% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
6.03×
This company
1.12×
Market median
+438% vs market
20202024
Debt / equity
21.91×
This company
0.62×
Market median
-3434% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SK Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2026 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 | |
| Individual | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Jks As
BLIKK ØYEKLINIKK AS Board members of BLIKK ØYEKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sandra Kristin Valla | Chief Executive Officer | 0 companies |
| Svein Ove Semb | Board of Directors | 0 companies |
| Jon Klokk Slettedal | Chairman | 0 companies |
| Per Bjørn Stordahl | Board of Directors | 0 companies |
| Bettina Kinge | Chairman | 0 companies |